ALVESCO
Drug
Covis Pharma GmbH
Total Payments
$3.3M
Transactions
7,811
Doctors
2,036
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $5,448 | 276 | 269 |
| 2022 | $40,795 | 2,112 | 1,160 |
| 2021 | $277,984 | 3,611 | 861 |
| 2020 | $2.9M | 643 | 279 |
| 2019 | $111,048 | 675 | 301 |
| 2018 | $7,749 | 494 | 302 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.1M | 21 | 92.7% |
| Food and Beverage | $144,016 | 7,648 | 4.3% |
| Consulting Fee | $97,433 | 28 | 2.9% |
| Education | $1,169 | 110 | 0.0% |
| Travel and Lodging | $212.14 | 4 | 0.0% |
Payments by Type
Research
$3.1M
21 transactions
General
$242,830
7,790 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ciclesonide Metered-Dose Inhaler in Non-Hospitalized Patients 12 Years of Age and Older With Symptomatic COVID-19 Infection | Covis Pharma GmbH | $2.9M | 0 |
| A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ciclesonide Metered-Dose Inhaler in Non-Hospitalized Patients 12 Years of Age and Older With Symptomatic COVID-19 Infection | Covis Pharma GmBH | $180,434 | 0 |
Top Doctors Receiving Payments for ALVESCO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Buffalo, NY | $3.1M | 21 |
| , M.D | Clinical & Laboratory Immunology | Springfield, NJ | $28,870 | 13 |
| , M.D | Allergy & Immunology | Roswell, GA | $19,401 | 6 |
| , M.D | Internal Medicine | Cincinnati, OH | $8,618 | 22 |
| , M.D., | Pediatric Allergy/Immunology | Miami Lakes, FL | $6,367 | 6 |
| , M.D | Allergy | Memphis, TN | $5,908 | 4 |
| , M.D | Allergy & Immunology | Kennesaw, GA | $5,727 | 19 |
| , M.D | Allergy & Immunology | Louisville, KY | $5,601 | 14 |
| , M. D | Allergy & Immunology | Charlotte, NC | $5,296 | 4 |
| Curtis Hedberg | — | Rogers, AR | $5,279 | 3 |
| , M.D | Allergy & Immunology | Jackson, MS | $5,279 | 3 |
| , MD | Allergy | Rochester, NY | $5,279 | 3 |
| , MD | Pediatric Pulmonology | Tampa, FL | $969.42 | 38 |
| , MD | Allergy & Immunology | Kennesaw, GA | $871.10 | 35 |
| , M.D | Allergy & Immunology | Chicago, IL | $806.98 | 38 |
| , MD | Allergy & Immunology | Chicago, IL | $744.14 | 35 |
| , MD | Allergy & Immunology | Columbus, OH | $731.56 | 62 |
| , MD | Allergy | Atlanta, GA | $702.10 | 40 |
| , MD | Specialist | Frisco, TX | $700.26 | 38 |
| , MD | Pediatric Pulmonology | Tampa, FL | $684.40 | 25 |
| , M.D | Allergy & Immunology | Arlington, TX | $673.22 | 40 |
| , M.D | Allergy & Immunology | Dallas, TX | $651.54 | 38 |
| , MD | Allergy | Dallas, TX | $641.69 | 39 |
| , MD | Allergy | Dallas, TX | $640.43 | 38 |
| , M.D | Allergy & Immunology | Arlington, TX | $634.76 | 37 |
Ad
Manufacturing Companies
- Covis Pharma GmbH $2.9M
- Covis Pharma GmBH $292,562
- Covis Pharma B.V. $117,171
- COVIS PHARMA B.V. $1,625
Product Information
- Type Drug
- Total Payments $3.3M
- Total Doctors 2,036
- Transactions 7,811
About ALVESCO
ALVESCO is a drug associated with $3.3M in payments to 2,036 healthcare providers, recorded across 7,811 transactions in the CMS Open Payments database. The primary manufacturer is Covis Pharma GmbH.
Payment data is available from 2018 to 2023. In 2023, $5,448 was paid across 276 transactions to 269 doctors.
The most common payment nature for ALVESCO is "Unspecified" ($3.1M, 92.7% of total).
ALVESCO is associated with 2 research studies, including "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ciclesonide Metered-Dose Inhaler in Non-Hospitalized Patients 12 Years of Age and Older With Symptomatic COVID-19 Infection" ($2.9M).